Compare TCBX & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBX | CTKB |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.8M | 595.2M |
| IPO Year | 2021 | 2021 |
| Metric | TCBX | CTKB |
|---|---|---|
| Price | $36.87 | $3.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $45.00 | $5.63 |
| AVG Volume (30 Days) | 71.2K | ★ 628.2K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.33 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $29.99 | $5.42 |
| Revenue Next Year | $10.14 | $7.03 |
| P/E Ratio | $42.21 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $29.68 | $2.37 |
| 52 Week High | $43.84 | $6.18 |
| Indicator | TCBX | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 40.36 | 28.96 |
| Support Level | $36.39 | $3.28 |
| Resistance Level | $38.86 | $4.26 |
| Average True Range (ATR) | 1.08 | 0.26 |
| MACD | -0.12 | -0.09 |
| Stochastic Oscillator | 23.53 | 0.74 |
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.